Biotech & Pharma

Cancer Drug Reduces SIV Reservoir in Macaques, May Inform HIV Cure Strategies

31 sec read13 views0 listens

Researchers at Emory University found that venetoclax, a cancer drug, reduced the SIV reservoir in macaques when administered alongside antiretroviral therapy. This discovery could inform strategies to eliminate HIV's latent viral reservoir, advancing potential cure approaches for HIV by leveraging an existing medication.

This development offers hope for accelerating HIV cure timelines and highlights the importance of cross-disciplinary research between oncology and virology. Further studies will explore longer dosing periods and mechanisms behind cell survival post-treatment.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

CybersecurityAug 2627 sec read

Canadian supercomputers are transforming drug discovery: Can they deliver medicines faster?

Researchers at Simon Fraser University have developed an AI framework called CGFlow, which accelerates the design of drug molecules by ensuring they can be synthesized in a laboratory. This advancement is crucial for reducing the time and cost associ...

Ali Nemati

Biotech & PharmaAug 1729 sec read

Human Cell Atlas at 10: A Decade of Discovery and the Road to HCA 2.0

The Human Cell Atlas (HCA) celebrated its 10-year anniversary, marking significant advancements in single-cell and spatial data generation for tissue and organ systems. The project is now transitioning to HCA 2.0, focusing on scaling spatial atlases,...

Ali Nemati

Biotech & PharmaAug 1723 sec read

Pharma Races to Scale AI as Billions Flow into Drug Discovery

Billion-dollar investments are pouring into end-to-end AI platforms for drug discovery, enabling more powerful biological models through integrated datasets and reasoning workflows. This trend is driven by the potential to accelerate biomedical resea...

Ali Nemati